Literature DB >> 3258521

Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis.

U Schmitz-Huebner1, S G Thompson, L Balleisen, C Fechtrup, W Grosse-Heitmeyer, B Kirchhof, E Most, U S Müller, C Seiffert, D Seiffert.   

Abstract

Blood samples were taken for haemostatic analysis from 225 patients with angina pectoris who were admitted to hospital for coronary angiography. beta thromboglobulin, platelet factor 3, platelet factor 4, factor VII:C, factor VIII:C, von Willebrand factor antigen, activated partial thromboplastin time, fibrinogen, antithrombin III, protein C:Ag, plasminogen, and antiplasmin were measured before angiography. Patients who had had a myocardial infarction in the two months before the investigation were excluded from the study. Multiple linear regression analysis showed that none of the haemostatic variables contributed independently to the prediction of an angiographic score that indicated the extent of coronary atherosclerosis. History of myocardial infarction, male sex, worsening of angina pectoris, serum triglycerides, and ejection fraction were independently associated with the angiographic score. There were some significant correlations between haemostatic variables and conventional risk factors for coronary heart disease. Thus data obtained from haemostatic analyses of peripheral venous blood do not permit the presence or the extent of atherosclerosis in coronary arteries to be predicted.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258521      PMCID: PMC1216461          DOI: 10.1136/hrt.59.3.287

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  25 in total

1.  The use of biplane angiocardigraphy for the measurement of left ventricular volume in man.

Authors:  H T DODGE; H SANDLER; D W BALLEW; J D LORD
Journal:  Am Heart J       Date:  1960-11       Impact factor: 4.749

Review 2.  Percutaneous transfemoral selective coronary arteriography.

Authors:  M P Judkins
Journal:  Radiol Clin North Am       Date:  1968-12       Impact factor: 2.303

3.  Left ventricular volume and mass from single-plane cineangiocardiogram. A comparison of anteroposterior and right anterior oblique methods.

Authors:  J W Kennedy; S E Trenholme; I S Kasser
Journal:  Am Heart J       Date:  1970-09       Impact factor: 4.749

4.  Platelet factor 4 levels in patients with coronary artery disease.

Authors:  G L White; A A Marouf
Journal:  J Lab Clin Med       Date:  1981-03

5.  Evaluation of an amidolytic heparin cofactor assay method.

Authors:  O R Odegård
Journal:  Thromb Res       Date:  1975-08       Impact factor: 3.944

6.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

7.  Increased plasma concentrations of platelet factor 4 in coronary artery disease: a measure of in vivo platelet activation and secretion.

Authors:  S P Levine; J Lindenfeld; J B Ellis; N M Raymond; L S Krentz
Journal:  Circulation       Date:  1981-09       Impact factor: 29.690

8.  Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate.

Authors:  A C Teger-Nilsson; P Friberger; E Gyzander
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

9.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

Authors:  M A DeWood; J Spores; R Notske; L T Mouser; R Burroughs; M S Golden; H T Lang
Journal:  N Engl J Med       Date:  1980-10-16       Impact factor: 91.245

10.  Circulating platelet products in unstable angina pectoris.

Authors:  M Sobel; E W Salzman; G C Davies; R I Handin; J Sweeney; J Ploetz; G Kurland
Journal:  Circulation       Date:  1981-02       Impact factor: 29.690

View more
  4 in total

1.  Lipid profile, haemostatic variables and angiographically-defined coronary artery disease: a cross-sectional study in an Irish population.

Authors:  J Galvin; M Codd; S Leavy; D Sugrue
Journal:  Ir J Med Sci       Date:  1996 Apr-Jun       Impact factor: 1.568

2.  Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis.

Authors:  S Wållberg-Jonsson; G H Dahlén; T K Nilsson; M Rånby; S Rantapää-Dahlqvist
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

3.  Lipid peroxides and atherosclerosis.

Authors:  M D Stringer; P G Görög; A Freeman; V V Kakkar
Journal:  BMJ       Date:  1989-02-04

4.  von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.

Authors:  J H Jansson; T K Nilsson; O Johnson
Journal:  Br Heart J       Date:  1991-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.